Alkermes (ALKS) Revenue (2010 - 2026)
Alkermes' (ALKS) quarterly Revenue came in at $496.0 million in Q2 2026, up 26.97% year-over-year from $390.7 million in Q2 2025, and up 26.24% quarter-over-quarter from $392.9 million in Q1 2026.
Analysis
Alkermes (ALKS) Revenue (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Revenue for 17 consecutive years, with $496.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Revenue rose 26.97% year-over-year to $496.0 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 10.79% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 5.25% from the prior year.
- Revenue was $496.0 million for Q2 2026 at Alkermes, up from $392.9 million in the prior quarter.
- Over five years, Revenue peaked at $617.4 million in Q2 2023 and troughed at $252.4 million in Q3 2022.
- A 5-year average of $372.1 million and a median of $379.5 million in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue jumped 123.52% in 2023 and plunged 35.35% in 2024, its largest moves.
- Over 5 years, Revenue stood at $304.7 million in 2022, then grew by 23.89% to $377.5 million in 2023, then advanced by 13.91% to $430.0 million in 2024, then dropped by 10.57% to $384.5 million in 2025, then advanced by 28.99% to $496.0 million in 2026.
- The last three Revenue figures came in at $496.0 million (Q2 2026), $392.9 million (Q1 2026), and $384.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 15.03 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 12.97 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 13.48 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 1.71 Bn |
| 10 | Alkermes | 7.27 Bn | 6.61 Bn | 397.90 Mn | 496.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 496.01 Mn |
| Mar 31, 2026 | 392.91 Mn |
| Dec 31, 2025 | 384.55 Mn |
| Sep 30, 2025 | 394.19 Mn |
| Jun 30, 2025 | 390.66 Mn |
| Mar 31, 2025 | 306.51 Mn |
| Dec 31, 2024 | 429.99 Mn |
| Sep 30, 2024 | 378.14 Mn |
| Jun 30, 2024 | 399.13 Mn |
| Mar 31, 2024 | 350.37 Mn |
| Dec 31, 2023 | 377.48 Mn |
| Sep 30, 2023 | 380.94 Mn |
| Jun 30, 2023 | 617.40 Mn |
| Mar 31, 2023 | 287.60 Mn |
| Dec 31, 2022 | 304.67 Mn |
| Sep 30, 2022 | 252.36 Mn |
| Jun 30, 2022 | 276.22 Mn |
| Mar 31, 2022 | 278.55 Mn |
| Dec 31, 2021 | 324.46 Mn |
| Sep 30, 2021 | 294.14 Mn |